Status | 即將出版Forthcoming |
STAT3-NAV2 axis as a new therapeutic target for rheumatoid arthritis via activating SSH1L/Cofilin-1 signaling pathway | |
Wang, Ran1,2; Cai, Jianghong1; Chen, Keyuan1; Zhu, Menglin1; Li, Zhaoyi1; Liu, Hua3; Liu, Tiantian1,3; Mao, Jianchun4; Ding, Qian1; Zhu, Yi Zhun1,5 | |
2022-12-01 | |
DOI | 10.1038/s41392-022-01050-7 |
Language | 英語English |
URL | View the original |
Scopus ID | 2-s2.0-85133582774 |
Fulltext Access | |
Citation statistics | |
Document Type | Other |
Collection | University of Macau |
Affiliation | 1.State Key Laboratory of Quality Research in Chinese Medicine, School of Pharmacy, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macao 2.School of Pharmacy, Minzu University of China, Beijing, 100081, China 3.Department of Pharmacy, Aerospace Center Hospital, Beijing, 100049, China 4.Department of Rheumatology, Longhua Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China 5.Shanghai Key Laboratory of Bioactive Small Molecules, Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai, 201203, China |
First Author Affilication | University of Macau |
Recommended Citation GB/T 7714 | Wang, Ran,Cai, Jianghong,Chen, Keyuan,et al. STAT3-NAV2 axis as a new therapeutic target for rheumatoid arthritis via activating SSH1L/Cofilin-1 signaling pathway. 2022-12-01. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment